These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31625597)

  • 1. A bivalent antihypertensive vaccine targeting L-type calcium channels and angiotensin AT
    Wu H; Wang Y; Wang G; Qiu Z; Hu X; Zhang H; Yan X; Ke F; Zou A; Wang M; Liao Y; Chen X
    Br J Pharmacol; 2020 Jan; 177(2):402-419. PubMed ID: 31625597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of a therapeutic vaccine against angiotensin II receptor type 1 in hypertensive animals.
    Chen X; Qiu Z; Yang S; Ding D; Chen F; Zhou Y; Wang M; Lin J; Yu X; Zhou Z; Liao Y
    Hypertension; 2013 Feb; 61(2):408-16. PubMed ID: 23184378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
    Ambühl PM; Tissot AC; Fulurija A; Maurer P; Nussberger J; Sabat R; Nief V; Schellekens C; Sladko K; Roubicek K; Pfister T; Rettenbacher M; Volk HD; Wagner F; Müller P; Jennings GT; Bachmann MF
    J Hypertens; 2007 Jan; 25(1):63-72. PubMed ID: 17143175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target organ protection from a novel angiotensin II receptor (AT1) vaccine ATR12181 in spontaneously hypertensive rats.
    Zhu F; Liao YH; Li LD; Cheng M; Wei F; Wei YM; Wang M
    Cell Mol Immunol; 2006 Apr; 3(2):107-14. PubMed ID: 16696897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy.
    Ding D; Du Y; Qiu Z; Yan S; Chen F; Wang M; Yang S; Zhou Y; Hu X; Deng Y; Wang S; Wang L; Zhang H; Wu H; Yu X; Zhou Z; Liao Y; Chen X
    J Mol Med (Berl); 2016 Feb; 94(2):207-18. PubMed ID: 26407577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal vaccination against angiotensin II type 1 receptor and pneumococcal surface protein A attenuates hypertension and pneumococcal infection in rodents.
    Azegami T; Yuki Y; Hayashi K; Hishikawa A; Sawada SI; Ishige K; Akiyoshi K; Kiyono H; Itoh H
    J Hypertens; 2018 Feb; 36(2):387-394. PubMed ID: 28832363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy.
    Azegami T; Sasamura H; Hayashi K; Itoh H
    Hypertens Res; 2012 May; 35(5):492-9. PubMed ID: 22158111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of D4 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells.
    Chen K; Deng K; Wang X; Wang Z; Zheng S; Ren H; He D; Han Y; Asico LD; Jose PA; Zeng C
    Hypertension; 2015 Jan; 65(1):153-60. PubMed ID: 25368031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of angiotensin II type-1 receptor antisense oligonucleotides on renal function in spontaneously hypertensive rats.
    Yoneda M; Sanada H; Yatabe J; Midorikawa S; Hashimoto S; Sasaki M; Katoh T; Watanabe T; Andrews PM; Jose PA; Felder RA
    Hypertension; 2005 Jul; 46(1):58-65. PubMed ID: 15956107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term treatment of stroke-prone spontaneously hypertensive rats with an AT1 receptor blocker protects against hypertensive end-organ damage by prolonged inhibition of the renin-angiotensin system.
    Hamaguchi R; Takemori K; Inoue T; Masuno K; Ito H
    Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1151-5. PubMed ID: 18518883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II activates Ca
    Kashihara T; Nakada T; Kojima K; Takeshita T; Yamada M
    J Physiol; 2017 Jul; 595(13):4207-4225. PubMed ID: 28295363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats.
    Zhou J; Pavel J; Macova M; Yu ZX; Imboden H; Ge L; Nishioku T; Dou J; Delgiacco E; Saavedra JM
    Stroke; 2006 May; 37(5):1271-6. PubMed ID: 16601219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats.
    Aritomi S; Harada E; Sugino K; Nishimura M; Nakamura T; Takahara A
    Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):344-52. PubMed ID: 25582553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-type calcium channels modulate the regression of left ventricular hypertrophy after ace-inhibition in genetic hypertension.
    Vulpis V; Lograno MD; Seccia TM; Pirrelli A
    Pharmacol Res; 1998 Oct; 38(4):317-22. PubMed ID: 9774496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Reduction of High Blood Pressure by Angiotensin II DNA Vaccine in Spontaneously Hypertensive Rats.
    Koriyama H; Nakagami H; Nakagami F; Osako MK; Kyutoku M; Shimamura M; Kurinami H; Katsuya T; Rakugi H; Morishita R
    Hypertension; 2015 Jul; 66(1):167-74. PubMed ID: 26015450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
    Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
    Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel dual action AT1 and ETA receptor antagonists reduce blood pressure in experimental hypertension.
    Kowala MC; Murugesan N; Tellew J; Carlson K; Monshizadegan H; Ryan C; Gu Z; Kane B; Fadnis L; Baska RA; Beyer S; Arthur S; Dickinson K; Zhang D; Perrone M; Ferrer P; Giancarli M; Baumann J; Bird E; Panchal B; Yang Y; Trippodo N; Barrish J; Macor JE
    J Pharmacol Exp Ther; 2004 Apr; 309(1):275-84. PubMed ID: 14718594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage.
    Nishikawa K
    J Hum Hypertens; 1998 May; 12(5):301-9. PubMed ID: 9655651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
    Lacour C; Canals F; Galindo G; Cazaubon C; Segondy D; Nisato D
    Eur J Pharmacol; 1994 Nov; 264(3):307-16. PubMed ID: 7698170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in protein and gene expression of angiotensin II receptors (AT1 and AT2) in aorta of diabetic and hypertensive rats.
    Romero-Nava R; Rodriguez JE; Reséndiz-Albor AA; Sánchez-Muñoz F; Ruiz-Hernandéz A; Huang F; Hong E; Villafaña S
    Clin Exp Hypertens; 2016; 38(1):56-62. PubMed ID: 26268856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.